We are open with limited hours and staff.
Price range: $155.00 through $757.00
Lortab 2.5/500mg is a historical hydrocodone bitartrate and acetaminophen combination. Each tablet contains 2.5mg of hydrocodone bitartrate and 500mg of acetaminophen. Older DailyMed labeling identifies this formulation for the relief of moderate to moderately severe pain.
Hydrocodone is an opioid analgesic that affects the central nervous system, while acetaminophen provides additional pain-relieving and fever-reducing effects. Therefore, the combination requires careful medical supervision.
The historical label also identifies Lortab 2.5/500mg as a prescription medicine and a Schedule III controlled substance. Hydrocodone may be habit-forming, so treatment should follow the instructions provided by a qualified healthcare professional.
Safety remains important with any medication containing hydrocodone. The opioid component can cause drowsiness, dizziness, impaired coordination, constipation, and respiratory depression. Consequently, patients should avoid combining it with alcohol, sedatives, or other medicines that can slow the central nervous system unless a healthcare professional specifically advises otherwise.
The acetaminophen component also requires attention. Excessive acetaminophen exposure can cause serious liver injury. For this reason, patients should check other medicines for acetaminophen before using multiple pain-relief products together.
Possible adverse effects may include nausea, vomiting, drowsiness, mental clouding, constipation, skin reactions, and dizziness. However, severe sleepiness, slow or difficult breathing, or difficulty waking requires immediate medical attention.
Lortab 2.5/500mg should only be used under appropriate medical direction. Patients should not share prescription medication, change the prescribed amount, or combine it with other medicines without professional advice.
Because this is an older formulation, product labeling and availability can differ from newer hydrocodone/acetaminophen products. Therefore, the actual medication label should always be checked to confirm the active ingredients and strength.
Patients should also discuss liver conditions, breathing problems, other medicines, alcohol use, pregnancy, and any history of substance misuse with their healthcare provider. Secure storage helps reduce accidental exposure and misuse.
Finally, people who develop physical dependence should not abruptly discontinue regular opioid treatment without medical guidance. A healthcare professional can determine whether gradual dose reduction is appropriate.
This content is for general educational purposes and does not replace advice from a licensed healthcare professional.
